StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Earnings

Perspective Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 15, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$20.00K
EPS, Q3 FY2026
-$0.27
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Perspective Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 15, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close$20.00K–-$0.27Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026after the close$81.00K-73.0%-$0.22Release
Q1 FY2026ended Mar 31, 2026May 4, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Mar 16, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Oct 20, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025before the open$300.00K0.0%-$0.29Release
Q1 FY2025ended Mar 31, 2025May 12, 2025after the close–––Release
Q4 FY2024ended Dec 31, 2024Mar 26, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$400.00K––Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024after the close$300.00K–-$0.02Release
Q1 FY2024ended Mar 31, 2024May 15, 2024before the open$300.00K–-$0.02Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Perspective Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Perspective Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Perspective Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. News
  5. News
  6. News
  7. News
  8. News
  9. News
  10. News
  11. News
  12. News
  13. News
  14. Results
  15. Results

See a number that looks wrong?